Press Releases

 

 
Press Releases
Date Title and Summary View
Apr 11, 2016 RANCHO CUCAMONGA, Calif., April 11, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President will be presenting at the 15th Annual Needham Healthcare Conference on Wednesday, April 13, 2016 at 12:50 p.m. Eastern Daylight Time in New York, NY....
Mar 14, 2016 RANCHO CUCAMONGA, Calif., March 14, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the fourth quarter and fiscal year ended December 31, 2015. F...
Mar 11, 2016 RANCHO CUCAMONGA, Calif., March 11, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its fourth quarter of 2015 ended December 31, 2015, after the market closes on Monday, March 14, 2016, and will hold a conference call to discuss its financial results at ...
Nov 24, 2015 RANCHO CUCAMONGA, Calif., Nov. 24, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") announced today that Jason Shandell, President and Bill Peters, CFO will be presenting at the 27th Annual Piper Jaffray Healthcare Conference on Tuesday, December 1, 2015 at 11:30 a.m. Eastern Standard Time in New...
Nov 12, 2015 RANCHO CUCAMONGA, Calif., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the third quarter ended September 30, 2015. Net revenues of $63.9 million for the third quarter GAAP net loss of $3.0 million, or $0.07 per diluted share for the ...
Nov 5, 2015 RANCHO CUCAMONGA, Calif., Nov. 5, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2015 ended September 30, 2015, after the market closes on Thursday, November 12, 2015, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific...
Oct 20, 2015 RANCHO CUCAMONGA, Calif., Oct. 20, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") announced today that it began shipping Amphadase® (hyaluronidase injection). This launch marks the first product made using starting material from the Company's subsidiary, ANP, located in Nanjing, China. ...
Aug 12, 2015 RANCHO CUCAMONGA, Calif., Aug. 12, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the second quarter ended June 30, 2015. Net revenues of $53.9 million for the second quarter GAAP net loss of $6.6 million, or $0.15 per diluted share for the sec...
Aug 4, 2015 RANCHO CUCAMONGA, Calif., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2015 ended June 30, 2015, after the market closes on Wednesday, August 12, 2015, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time...
Jun 22, 2015 RANCHO CUCAMONGA, Calif., June 22, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) ("Amphastar" or the "Company") announced today that the U.S. Food and Drug Administration ("FDA") granted approval of the Company's New Drug Application ("NDA") supplement for Amphadase® (hyaluronidase injection). This marks the first FDA ...
Page: FirstPrevious
4
NextLast
= add release to Briefcase

 

Copyright © 2017 Amphastar Pharmaceuticals, Inc.

Privacy      Terms & Conditions

This site is intended for residents of the United States